EMATRA 10MG CAP. 100 CAP

About

EMATRA (hypothetical oral targeted therapy) is an oral medication designed to selectively inhibit specific molecular pathways involved in cancer cell growth and proliferation. It belongs to the class of targeted therapies, which work by interfering with particular molecules essential for tumor development, rather than broadly affecting all rapidly dividing cells like traditional chemotherapy. This targeted approach aims to offer more precise treatment with potentially fewer systemic side effects.

EMATRA is typically prescribed for specific types of cancer that express the molecular target it inhibits, as identified through diagnostic testing. It is taken orally, offering convenience for long-term management. Its mechanism of action focuses on disrupting signaling cascades that drive tumor progression, leading to inhibition of cell division, induction of apoptosis, and suppression of angiogenesis. Regular monitoring is essential to assess efficacy and manage any potential adverse reactions.

Uses

• Specific types of solid tumors with identified molecular targets
• Advanced or metastatic cancers
• Maintenance therapy after initial treatment
• When conventional therapies are ineffective or not tolerated

Directions For Use

Take orally once daily with or without food, as directed by your doctor. Do not crush, chew, or open the capsules.

Benefits

• Targeted action against cancer cells
• Oral administration offers convenience
• Potentially fewer systemic side effects than traditional chemotherapy
• May improve progression-free survival
• Can be used for long-term disease management
• Effective in specific patient populations

Side Effects

• Fatigue
• Nausea and vomiting
• Diarrhea
• Skin rash
• Headache
• Muscle or joint pain
• Loss of appetite
• Elevated liver enzymes
• Hypertension
• Peripheral edema
• Hair changes
• Stomatitis

Safety Measures

• Alcohol - Limit alcohol intake as it may increase the risk of liver toxicity and exacerbate gastrointestinal side effects.
• Pregnancy - Contraindicated in pregnancy due to potential fetal harm. Effective contraception is required for both male and female patients during and for a period after treatment.
• Breastfeeding - Breastfeeding is not recommended during treatment and for a period after the last dose due to potential harm to the infant.
• Liver - Use with caution in patients with pre-existing liver impairment; dose adjustments may be necessary. Regular monitoring of liver function is essential.
• Kidney - Use with caution in patients with pre-existing renal impairment. Dose adjustments may be required, and kidney function should be closely monitored.
• Lung - Monitor for new or worsening pulmonary symptoms, such as interstitial lung disease, which can be a rare but serious side effect of some targeted therapies.

Disclaimer

MedEHub is committed to delivering reliable, expert-reviewd information to help consumers make informed health decisions. However, the content provided on this website is for informational purposes only and is not intended to replace professional medical advice, diagnosis or treatment.

Always consult your doctor for any medical concerns, and discuss your questions about health conditions or medications with a qualified healthcare professional. Do not ignore or delay seeking professional medical advice based on information found on Med E Hub.

Our goal is to complement, not replace, the essential doctor-patient relationship.